Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Thromboembolic events in gastric cancer: high incidence in patients receiving irinotecan- and bevacizumab-based therapy.

× No keyword cloud information.

35 in total

1. Evaluating coagulation disorders in the use of bevacizumab for metastatic colorectal cancer by thrombelastography.

Authors: Zeki Ustuner; O Meltem Akay; Muge Keskin; Esin Kuş; Cengiz Bal; Zafer Gulbas
Journal: Med Oncol Date: 2012-06-14 Impact factor: 3.064

2. Antibody-based targeted therapy for gastric cancer.

Authors: Florian Lordick; Christian Peschel; Jörg Rüdiger Siewert
Journal: Gastric Cancer Date: 2005 Impact factor: 7.370

3. Bevacizumab in combination with FOLFIRI chemotherapy in patients with metastatic colorectal cancer: an assessment of safety and efficacy in the province of Newfoundland and Labrador.

Authors: G Dranitsaris; S Edwards; J Edwards; M Leblanc; R Abbott
Journal: Curr Oncol Date: 2010-10 Impact factor: 3.677

Review 4. [Intravitreal injection. Monitoring to avoid postoperative complications].

Authors: C H Meyer; F Ziemssen; H Heimann
Journal: Ophthalmologe Date: 2008-02 Impact factor: 1.059

5. Chemoradiotherapy for esophageal cancer.

Authors: Geoffrey Neuner; Ashish Patel; Mohan Suntharalingam
Journal: Gastrointest Cancer Res Date: 2009-03

6. Gastroesophageal cancer: understanding the disease process and advancing therapy.

Authors: John S Macdonald
Journal: Gastrointest Cancer Res Date: 2007-03

7. Cost-effectiveness of bevacizumab and ranibizumab for newly diagnosed neovascular macular degeneration.

Authors: Joshua D Stein; Paula Anne Newman-Casey; Tavag Mrinalini; Paul P Lee; David W Hutton
Journal: Ophthalmology Date: 2014-01-07 Impact factor: 12.079

Review 8. Role of receptor tyrosine kinases in gastric cancer: new targets for a selective therapy.

Authors: J C Becker; C Muller-Tidow; H Serve; W Domschke; T Pohle
Journal: World J Gastroenterol Date: 2006-06-07 Impact factor: 5.742

9. Portal thrombosis and steatosis after preoperative chemotherapy with FOLFIRI-bevacizumab for colorectal liver metastases.

Authors: Matteo Donadon; Jean-Nicolas Vauthey; Evelyne M Loyer; Chusilp Charnsangavej; Eddie K Abdalla
Journal: World J Gastroenterol Date: 2006-10-28 Impact factor: 5.742

10. Intravitreal bevacizumab: an analysis of the evidence.

Authors: Derrick P Smit; David Meyer
Journal: Clin Ophthalmol Date: 2007-09